Genetically modified CD34+ cells exert a cytotoxic bystander effect on human endothelial and cancer cells

Clinical Cancer Research

Volumn 6, Issue 11, 2000, Pages 4442-4448

  Arafat, Waleed O ^a,d   Casado, Enrique ^a   Wang, Minghui ^d   Alvarez, Ronald D ^c,d   Siegal, Gene P ^b,d   Glorioso, Joseph C ^e   Curiel, David T ^a,d   Go´mez Navarro, Jesu´s ^a,d  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; VIRUS VECTOR;

ARTICLE; CYTOTOXICITY; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL; TUMOR BLOOD FLOW;

ANIMALS; ANTIGENS, CD34; ENDOTHELIUM, VASCULAR; FEMALE; GANCICLOVIR; GENE THERAPY; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; NEOPLASMS; SIMPLEXVIRUS; TUMOR CELLS, CULTURED;

EID: 0033748797     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Gene therapy for cancer
2. Cancer gene therapy: Hard lessons and new courses
3. Human gene transfer: Characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man
4. Lymphocytes as cellular vehicles for gene therapy in mouse and man
5. T Lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years
6. Cell therapy
7. Endothelial cell vehicles for delivery of cytotoxic genes as a gene therapy approach for carcinoma of the ovary
8. Isolation of putative progenitor endothelial cells for angiogenesis
9. Evidence for circulating bone marrow-derived endothelial cells
10. Human cord blood progenitors sustain thymic T-cell development and a novel form of angiogenesis
11. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors
12. Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model
13. Characterization and properties of cultured human von Willebrand umbilical vein endothelial cells
14. Rapid method for construction of recombinant HSV gene transfer vectors
15. Improved FACS-Gal: Flow cytometric analysis and sorting of viable eukaryotic cells expressing reporter gene constructs
16. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir
17. Cellular suicide therapy of malignant disease
18. Tentative novel mechanism of the bystander effect in glioma gene therapy with HSV-TK/GCV system
19. The bystander effect: Tumor regression when a fraction of the tumor mass is genetically modified
20. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 91 gliomas in rats
21. Gene transfer into humans - Immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction
22. The genetic modification of T cells for cancer therapy: An overview of laboratory and clinical trials
23. Tumor-specific T-bodies: Towards clinical application
24. Angiogenesis-directed implantation of genetically modified endothelial cells in mice
25. A novel endothelial cell-based gene therapy platform for the in vivo delivery of apolipoprotein E
26. Stem cell therapy and gene transfer for regeneration
27. Stem cells: Units of development, units of regeneration, and units in evolution